BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 2039690)

  • 1. Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
    Embleton MJ; Charleston A; Robins RA; Pimm MV; Baldwin RW
    Br J Cancer; 1991 May; 63(5):670-4. PubMed ID: 2039690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capture of recombinant ricin A chain by a bispecific anti-RTA:anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude mice.
    Pimm MV; Robins RA; Baldwin RW
    J Cancer Res Clin Oncol; 1992; 118(5):367-70. PubMed ID: 1583066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor.
    Frankel AE; Fu T; Burbage C; Chandler J; Willingham MC; Tagge EP
    Leukemia; 1997 Jan; 11(1):22-30. PubMed ID: 9001414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells.
    Levin LV; Griffin TW; Childs LR; Davis S; Haagensen DE
    Cancer Immunol Immunother; 1987; 24(3):202-6. PubMed ID: 3496151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma.
    Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham MC
    Biochemistry; 1996 Nov; 35(47):14749-56. PubMed ID: 8942636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody-ricin A chain conjugates (immunotoxins): potential therapeutic agents for human colon carcinoma.
    Gallagher WJ; Burk MW
    J Surg Res; 1986 Feb; 40(2):159-66. PubMed ID: 3945071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
    Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-lectin site ricin B chain mutants expressed in insect cells have residual galactose binding: evidence for more than two lectin sites on the ricin toxin B chain.
    Fu T; Burbage C; Tagge E; Chandler J; Willingham M; Frankel A
    Bioconjug Chem; 1996; 7(6):651-8. PubMed ID: 8950484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
    Kornfeld SB; Leonard JE; Mullen MD; Taetle R
    Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.
    Lambert JM; Goldmacher VS; Collinson AR; Nadler LM; Blättler WA
    Cancer Res; 1991 Dec; 51(23 Pt 1):6236-42. PubMed ID: 1718599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.
    Byers VS; Pawluczyk I; Berry N; Durrant L; Robins RA; Garnett MC; Price MR; Baldwin RW
    J Immunol; 1988 Jun; 140(11):4050-5. PubMed ID: 2453564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.
    Durrant LG; Byers VS; Scannon PJ; Rodvien R; Grant K; Robins RA; Marksman RA; Baldwin RW
    Clin Exp Immunol; 1989 Feb; 75(2):258-64. PubMed ID: 2784738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and secretion of a recombinant ricin immunotoxin from murine myeloma cells.
    Krek CE; Ladino CA; Goldmacher VS; Blättler WA; Guild BC
    Protein Eng; 1995 May; 8(5):481-9. PubMed ID: 8532670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential neutralizing activities of a single domain camelid antibody (VHH) specific for ricin toxin's binding subunit (RTB).
    Herrera C; Vance DJ; Eisele LE; Shoemaker CB; Mantis NJ
    PLoS One; 2014; 9(6):e99788. PubMed ID: 24918772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ricin A immunotoxins of IgG and Fab of anti-CALLA monoclonal antibody: effect of water soluble long-chain SPDP on conjugate yield, immunoselectivity and cytotoxicity.
    Woo BH; Lee JT; Lee KC
    Arch Pharm Res; 1994 Dec; 17(6):452-7. PubMed ID: 10319157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cytotoxicity of a ricin A-chain-anti-carcinoembryonic antigen antibody conjugate for a human colon adenocarcinoma cell line.
    Griffin TW; Haynes LR; DeMartino JA
    J Natl Cancer Inst; 1982 Oct; 69(4):799-805. PubMed ID: 6956757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
    Pietersz GA; Kanellos J; McKenzie IF
    Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.
    Woo BH; Lee JT; Park MO; Lee KR; Han JW; Park ES; Yoo SD; Lee KC
    Arch Pharm Res; 1999 Oct; 22(5):459-63. PubMed ID: 10549572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Supercluster of Neutralizing Epitopes at the Interface of Ricin's Enzymatic (RTA) and Binding (RTB) Subunits.
    Poon AY; Vance DJ; Rong Y; Ehrbar D; Mantis NJ
    Toxins (Basel); 2017 Nov; 9(12):. PubMed ID: 29168727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
    Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G
    Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.